What is the difference between Ritalin (methylphenidate) and dexamphetamine (dextroamphetamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ritalin and dexamphetamine are both effective treatments for ADHD, but dexamphetamine is generally considered to have a stronger effect and longer duration of action, making it a preferred option for some patients 1. When deciding between Ritalin and dexamphetamine, several factors should be considered, including the patient's age, severity of symptoms, and presence of comorbidities.

  • The mode of action of the two medications differs, with Ritalin primarily blocking dopamine reuptake and dexamphetamine both blocking reuptake and increasing dopamine release in the brain.
  • Dosing for Ritalin usually starts at 5-10mg taken 2-3 times daily, while dexamphetamine typically starts at 5mg once or twice daily.
  • Both medications are available in immediate and extended-release formulations, with extended-release versions providing longer coverage throughout the day.
  • Side effects for both can include decreased appetite, sleep difficulties, increased heart rate, and potential anxiety, though individual responses vary significantly.
  • According to a study published in the Journal of the American Academy of Child and Adolescent Psychiatry, the dosage of stimulant medications, including Ritalin and dexamphetamine, should be titrated upward in 5- to 10-mg intervals each week until symptoms are controlled 1.
  • The study also suggests that adults or older adolescents may be started on doses of 5 mg of Ritalin, dexamphetamine, or mixed-salts amphetamine, with titration upward in 5- to 10-mg intervals each week until symptoms are controlled.
  • It is essential to regularly assess medication adherence and potential issues in adherence, and to openly discuss these with the patient, as lack of adherence may lead to reduced effectiveness, increased adverse events, and other consequent problems 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Comparison of Ritalin and Dexamphetamine

  • Ritalin, also known as methylphenidate, and dexamphetamine are both central nervous system (CNS) stimulants used to treat Attention Deficit Hyperactivity Disorder (ADHD) 2, 3, 4, 5, 6.
  • The choice between Ritalin and dexamphetamine depends on various factors, including the patient's response to the medication, presence of comorbid conditions, and potential side effects 2, 5.
  • Studies have shown that both Ritalin and dexamphetamine can be effective in reducing symptoms of ADHD, but the evidence is not always consistent and can be influenced by various factors such as study design and population 3, 4, 6.

Efficacy and Safety

  • Ritalin has been shown to be effective in reducing symptoms of ADHD in adults, but the evidence is limited and the certainty of the evidence is often low 3, 4.
  • Dexamphetamine has been shown to be effective in reducing symptoms of ADHD, but its use is often limited by concerns about its potential for abuse and dependence 5, 6.
  • Both Ritalin and dexamphetamine can have side effects, including gastrointestinal complications, loss of appetite, and cardiovascular adverse events 3, 4, 6.

Clinical Recommendations

  • The use of Ritalin and dexamphetamine should be guided by clinical guidelines and recommendations, taking into account the individual patient's needs and circumstances 2, 5.
  • Clinicians should carefully evaluate the potential benefits and risks of each medication and consider alternative treatments, such as non-stimulant medications or behavioral therapies, when necessary 2, 5.
  • Further research is needed to fully understand the efficacy and safety of Ritalin and dexamphetamine in different populations and to inform clinical decision-making 3, 4, 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.